Melan-A Antibodies

Santa Cruz Biotechnology features a diverse variety of Melan-A Antibodies for research in the field of melanoma and related studies. Melan-A Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Melan-A, also known as MART-1, is a melanocyte differentiation antigen that plays a crucial role in the development and progression of melanoma. It is primarily expressed in melanocytes and melanoma cells, serving as a key target for immunotherapy and diagnostic applications. The study of Melan-A continues to reveal important insights into melanoma biology and potential treatment strategies. Researchers worldwide rely on Melan-A detection for investigating melanoma progression and metastasis. Understanding Melan-A expression patterns helps identify new therapeutic approaches and diagnostic methods. Ongoing research with Melan-A monoclonal antibodies from Santa Cruz Biotechnology contributes significantly to advancing melanoma research and treatment development in the scientific community.